LFA
BIIB icon

Legacy Financial Advisors’s Biogen BIIB Stock Holding History

Legacy Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-434
Closed -$103K – 213
2019
Q1 		$103K Sell
434
-22
-5% -$6.93K 0.03% 155
2018
Q4 		$137K Sell
456
-99
-18% -$31.6K 0.05% 124
2018
Q3 		$196K Hold
555
– – 0.07% 106
2018
Q2 		$193K Sell
555
-314
-36% -$88.3K 0.07% 106
2018
Q1 		$230K Buy
+869
New +$270K 0.09% 99

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Legacy Financial Advisors's BIIB Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Biogen (BIIB) in Q2 2019, closing a stake of 434 shares — an estimated $103K sold.

Legacy Financial Advisors first reported a position in BIIB in Q1 2018 and held it in 5 quarters. The position peaked at $230K in Q1 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 434 Biogen shares in Q2 2019, an estimated $103K.
  • Legacy Financial Advisors first reported a position in Biogen in Q1 2018 and held it in 5 quarters.
  • Legacy Financial Advisors's Biogen position peaked at $230K in Q1 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.